EMJ Podcast: Insights For Healthcare Professionals

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and treated. In this episode, Ken Herrmann reflects on his journey into nuclear medicine, the rapid evolution from PET to PET-CT, and the rise of theranostics. He discusses the balance between innovation and evidence, the growing role of multidisciplinary cancer care, and what lies ahead for the field, including the potential impact of AI. This is a forward-looking conversation for clinicians and researchers at every stage of their career.

Timestamps:

00:00 – Introduction

01:07 – His journey into nuclear medicine

02:45 – Impact of nuclear medicine

03:49 – The evolution of his research

05:22 – Theranostics

06:35 – What is the next breakthrough?

08:20 – Balancing innovation with evidence-based practice

09:45 – Multidisciplinary cancer care

11:30 – Biggest challenges in nuclear medicine

13:42 – Future of nuclear medicine

14:58 – Advice to early-career clinicians

16:00 – The potential of AI

17:57 – Three magic wishes for healthcare

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and treated. In this episode, Ken Herrmann reflects on his journey into nuclear medicine, the rapid evolution from PET to PET-CT, and the rise of theranostics. He discusses the balance between innovation and evidence, the growing role of multidisciplinary cancer care, and what lies ahead for the field, including the potential impact of AI. This is a forward-looking conversation for clinicians and researchers at every stage of their career.

Timestamps:

00:00 – Introduction

01:07 – His journey into nuclear medicine

02:45 – Impact of nuclear medicine

03:49 – The evolution of his research

05:22 – Theranostics

06:35 – What is the next breakthrough?

08:20 – Balancing innovation with evidence-based practice

09:45 – Multidisciplinary cancer care

11:30 – Biggest challenges in nuclear medicine

13:42 – Future of nuclear medicine

14:58 – Advice to early-career clinicians

16:00 – The potential of AI

17:57 – Three magic wishes for healthcare

In this episode, Wijedoru explains what social health really means and why it has been neglected for so long. Drawing on WHO frameworks and global experience, he explores how poor social health affects patients, communities, and healthcare systems, and why prevention must start with connection.Timestamps:01:10 – Background03:27 – Storytelling05:25 – Social health10:04 – WHO commission

Lalith Wijedoru answers rapid-fire questions on healthcare culture, loneliness, and emotional wellbeing. From lessons learned in low-resource settings to bold ideas for improving connection in hospitals, this episode introduces social health as a vital but under-recognised pillar of health.

In this final episode, Vallier explores the next steps for liver regeneration research, including stimulating liver regeneration with small molecules and lifestyle factors. He describes AI as a tool that should not be used in the wrong way, before wrapping up the discussion with his predictions for the next 5 years and the introduction of induced pluripotent stem cell clinical trials.

Timestamps:00:55 – Research beyond organoids

02:01 – Lifestyle factors

03:47 – Research funding

04:13 – AI in biotechnology

05:13 – Future of regenerative medicine

07:04 – Vision for stem cell therapies

In the second episode of the series, Vallier dives into clinical translation of research to different forms of liver disease, exploring how organoids may serve as an alternative to liver transplantation, and how immune compatibility differs between the two.

Timestamps:00:59 – Organoids versus transplantation

02:52 – Organoid immune compatibility

04:58 – Chronic liver diseases

06:15 – Clinical application

In this episode of Hema Now, Catherine Glass sits down with senior leaders from the European Association for Haemophilia and Allied Disorders (EAHAD) to go behind the scenes of the EAHAD 2026 Congress. The discussion explores the vision shaping the meeting, how the scientific programme is developed, and the key advances and challenges influencing haemophilia care across Europe, offering valuable insight for clinicians and researchers alike.

Timestamps:

00:00 – Introduction

01:41 – Vision of the EAHAD 2026 Congress

03:09 – Overview of the programme

06:46 – Behind the scenes of planning a congress

09:38 – New sessions to look out for

11:03 – Their programme highlights

13:38 – How the programme is curated

15:21 – Current landscape of haemophilia care in Europe

18:09 – Major advances in the field

20:25 – Unmet needs for patients

23:31 – Real-world data and registries

25:58 – Advice to young clinicians

27:28 – Hopes for the future of haemophilia care

30:21 – Their wishes for healthcare

In the final podcast of this three-part series, we hear expert insights into evolving guidelines, practical tools, and multidisciplinary collaboration for the optimal diagnosis and management of RCC.

Explore how healthcare professionals navigate RCC in daily practice, including the latest guidelines to the streamlining of referral pathways and evaluating treatment response.

In this first deep dive, Vallier discusses the current state of liver regeneration research. He explores how pluripotent stem cells can generate hepatocytes and biliary cells, and describes how organoids integrate into tissues whilst providing new insights into liver disease.

Timestamps:

00:53 – Liver regeneration at present

03:37 – Pluripotent stem cells

05:18 – Scaling clinical use of organoids

06:42 – Application to non-alcoholic fatty liver disease

09:22 – Ethical considerations

Ludovic Vallier joins the EMJ Podcast to answer rapid-fire questions about how regenerative technologies can be harnessed to tackle metabolic liver disease. From the biggest breakthroughs in regenerative hepatology to clinical misconceptions about stem cells, explore how this field of research is changing the liver disease landscape.